Many people can’t wait to get a Covid-19 vaccine. But people in Europe are balking at taking one developed by @AstraZeneca - after the EU pressured the company to supply more vaccines. With @margheritamvs @NBisserbe @WSJ wsj.com/articles/these…
Health-worker unions say thousands of their members refuse to take one of the three Covid-19 vaccines available in the region because of concerns over efficacy and reports of side effects, the latest setback for the EU’s slow rollout wsj.com/articles/these…
After demanding that @AstraZeneca deliver more doses to the bloc, some EU leaders criticized the vaccine. French President Emmanuel Macron said last month that the shot was “quasi-ineffective” for people over 65 wsj.com/articles/these…
However, trials of all authorized vaccines, including AstraZeneca’s, found that they offered 100% protection from severe illness, hospitalizations and death. wsj.com/articles/these…
Domenico Pianese, secretary-gen of the Italian police union Coisp, wrote in an open letter last week: “The decision to inoculate police forces with the AstraZeneca vaccine, which has the lowest level of efficacy, is inconceivable.” wsj.com/articles/these…
In the German state of Saarland, health authorities said more than half of 200 health professionals who were due to receive the AstraZeneca shot last weekend had failed to show up without warning. wsj.com/articles/these…
“Common sense dictates that one needs to get vaccinated in this pandemic and those who delay that are risking severe illness, and they also risk passing the virus onto others,” German Health Minister @jensspahn said wsj.com/articles/these…
One feature of the AstraZeneca vaccine that is sparking reluctance is the strong reaction—including headaches, fever, muscle pain and fatigue—reported by some recipients. Experts say this is normal and linked to the immune reaction wsj.com/articles/these…
AstraZeneca's contract to supply the UK with 100 million Covid-19 vaccine doses commits it to making "best reasonable efforts," the same language used in its deal with the European Union, which critics blamed for the bloc's faltering inoculation program cnn.com/2021/02/17/eur…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
A majority of foreign-born Germans and their offspring now support center-right parties, a development showing how decades of immigration into Europe has transformed the continent’s demographics and is reshaping politics in unexpected ways. My @WSJ report wsj.com/articles/immig…
Germans with foreign roots are increasingly voting for the center-right, providing a new pool of voters for Merkel's conservatives as the country’s social fabric becomes increasingly diverse & traditional political allegiances dissolve with integration wsj.com/articles/immig…
“We are seeing a process of normalization,” said Viola Neu, the author of the study. As migrants become economically & culturally more integrated, get naturalized & gain the right to vote, they tend to shift support from the center-left to the center-right wsj.com/articles/immig…
Some facts on EU vaccine procurement: 1. The EU only ordered 200m doses from @BioNTech_Group & @pfizer on *November 11,* when it was already behind in the queue (the US ordered on July 22). The EU *refused* an offer to order 500m doses.
2. Despite the BioNTech/Pfizer jab winning the global race, the EU stuck to 200m. On November 17 however it ordered 400m doses from CureVac, German firm that hadn't even started Phase3 trial. Only on *December 29* did the EU order additional 100m, again trailing the US
3. Data indicating that BioNTech/Pfizer were ahead of the pack emerged already in July. On *October 6* the EU regulator EMA started a rolling review based on extremely promising late-stage trial data, which was obviously available to EU officials wsj.com/articles/germa…
Big scoop: health ministers in EU’s pharma powers Germany,France,Italy & Netherlands joined forces to obtain vaccines for the bloc (kinda nascent EU Op Warpspeed) but their leaders forced them to abdicate responsibility to the Commission, which then failed to get enough doses 1/3
This is the letter sent by the healthcare minister to the Commission, drafted in slightly apologetic tone, asking the EU executive to take over vaccine procurement. Result: the EU, pop 450m, is now stuck with mere 200m BioNTech-Pfizer and 80m Moderna jabs by the autumn (at best).
Meanwhile, the new coronavirus variant that has spread from Britain could make obtaining herd immunity more difficult: as many as 80% of the population might need to be immunised to halt the pandemic wsj.com/articles/covid…
The U.S., Canada and U.K. have started vaccinating, but the region where the Pfizer-BioNTech shot was developed is still waiting for it. Europeans are becoming unsettled with the wait as pressure grows on regulators to act fast. With @drewhinshaw wsj.com/articles/europ…
The EU’s chief drug regulator EMA is coming under pressure from some governments to authorize a Covid-19 vaccine designed and produced on EU soil, as the continent struggles to contain a deadly wave of cases ahead of Christmas wsj.com/articles/europ…
At an EU summit last week, at least three heads of government complained that it was becoming politically untenable to explain to their citizens why the U.S. and Canada were administering a Europe-made vaccine ahead of the EU wsj.com/articles/europ…
The Swedish #Covid-19 experiment is over. After a severe second #coronavirus wave - which authorities said won’t happen - the government imposed some mandatory restrictions to curb hospitalisations and deaths. My report via @WSJ wsj.com/articles/long-…
After a surge in Covid-19 infections led to rising hospitalizations and deaths, Sweden has abandoned its attempt—unique among Western nations—to combat the pandemic through voluntary measures alone @WSJwsj.com/articles/long-…
With total Covid-19-related deaths reaching almost 700 per million inhabitants, infections growing exponen-tially and hospital wards filling up, the government had to shift wsj.com/articles/long-…
Pre-Brexit, the U.K. regulator’s massive portfolio of Europe-wide medicine evaluations (about 370). The agency has top staff - ~1,300 to EMA's ~900 - and is able to act much quicker outside the EU committee system. Brexit have it political license, too wsj.com/articles/how-t…
U.K. used emergency powers to authorize drugs on its own, allowing the MHRA to review the drug outside the EU framework even before the end of the Brexit transition period. All other EU members have the same power, but none have declared plans to use it wsj.com/articles/how-t…